Mezzion Competitors

The SFJ Pharmaceuticals Group is a Specialty Pharma Company deploying a new business model for the clinical development and registration of pharmaceutical products. Established in 2009, SFJ provides a financially advantageous and creative alternative approach to partnering. SFJ can provide the strategic financing, clinical development and regulatory resources for the clinical development and approval or your products. SFJ is staffed with a seasoned team of professionals, with extensive experience in the clinical development and regulatory approval of pharmaceutical products on a global basis. SFJ has offices in the United States, Europe, Japan, Singapore, Caymans, and Korea.

Beta Pharma is an emerging specialty pharmaceutical company dedicated to the discovery, development and commercialization of innovative late stage therapies targeting oncology. Our products pipeline is diverse and undergoing rapid development. Beta Pharma Inc. was founded in 1996, at Science Park of Yale, as a contract research organization (named Beta Chemicals Inc.) to provide custom synthesis service for the pharmaceutical and biotechnology R&D community. In May of 2006, our novel EGFR inhibitor, Icotinib, entered into a Phase I clinical trial in China. The SFDA approved Icotinib on June 7, 2011. The global registration of Icotinib is undergoing, with our regional partners worldwide.

Sciecure Pharma, Inc. is a US based, specialty pharmaceutical company, driven by a highly dedicated team, with 10,000 sq-ft laboratory and office space in Monmouth Junction, New Jersey. The current focus of the company is on research and development of high barrier drug products.